Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 81 | ECE2022 | Next issue

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

Card image cap
The 24th European Congress of Endocrinology (ECE) and the Italian Society of Endocrinology look forward to welcoming you to Milan. ECE 2022 returns for a four day, six parallel session festival of endocrine science. You can join us In person in Milan, Italy OR Live @Home online!

Rapid Communications

Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2

ea0081rc13.1 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

HPA axis modulation by a potent inhibitor indicates 11β-hydroxysteroid dehydrogenase type 1 (HSD-1) is a main source of cortisol that can bind intracellular receptors

Katz David , Mortier Mark

Background: HSD-1 converts cortisone to cortisol in tissues in which cortisol excess is associated with morbidity including liver, adipose, bone, and brain. SPI-62 is a potent HSD-1 inhibitor in clinical development for treatment of Cushing’s syndrome and autonomous cortisol secretion, and as adjunctive therapy to prednisolone in polymyalgia rheumatica. In Phase 1 clinical trials SPI-62 was generally well tolerated and associated with maximal liver and brain HSD-1 inhibit...

ea0081rc13.2 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Age- and gender-specific cut-off levels may improve DHEAS as a marker for suppressed HPA-axis

Puvaneswaralingam Shobitha , Olsen Henrik

Background: Low levels of DHEAS, such as <1.04 µmol/l, have been used as a criterion for autonomous cortisol secretion (ACS) in patients with adrenal incidentalomas. Age- and gender-specific cut-off levels could theoretically improve DHEAS as a marker of HPA-axis suppression and as a criterion for ACS.Objective: We aimed to find cut-off levels of DHEAS that are best associated with HPA-axis suppression and determine whether they are correlated w...

ea0081rc13.3 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Steroidomic approach for the characterization of patients with non-alcoholic fatty liver disease

Parasiliti Caprino Mirko , Rosso Chiara , Ponzetto Federico , Paolo Caviglia Gian , Lopez Chiara , Armandi Angelo , Maria Saracco Giorgio , Ghigo Ezio , Bugianesi Elisabetta , Maccario Mauro

Introduction: The onset and progression of liver damage in non-alcoholic fatty liver disease (NAFLD) is tightly associated with metabolic derangements. Steroids may affect lipid metabolism but their alterations in the setting of NAFLD remain to be fully explored.Patients and Methods: We analyzed data from 121 patients with biopsy-proven NAFLD and 108 controls (CT). A panel of 26 steroids (including glucocorticoids, mineralocorticoids, androgens, and prog...

ea0081rc13.4 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Analysis of the body composition and glucose metabolism in relation to bcli glucocorticoid receptor polymorphism in women with adrenal incidentalomas

Ognjanovic Sanja , Popovic Bojana , Ilic Dusan , Elezovic Valentina , Antic Jadranka , Opalic Milica , Radic Lena , Macut Djuro P

Single nucleotide polymorphisms in the glucocorticoid receptor (GR) gene influence tissue sensitivity of GR. Several studies have shown different effects of BclI GR polymorphism on body composition and metabolic parameters. The objective of this study was to explore the effect of BclI GR polymorphism on the body composition and glucose metabolism. Biochemical tests and hormonal evaluation were performed in 106 consecutive women with adrenal incidentalomas (AI...

ea0081rc13.5 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Skeletal muscle mass in patients with adrenal incidentaloma

Colombin Giacomo , Vara Giulio , Fanelli Flaminia , Magagnoli Matteo , Tucci Lorenzo , Coscia Kimberly , Mosconi Cristina , Pagotto Uberto , Vicennati Valentina , Di Dalmazi Guido

Background and aim: The relationship between sarcopenia and overt cortisol excess as in Cushing’s syndrome is well-known. However, only a few studies investigated the relationship between autonomous cortisol secretion (ACS) in adrenal incidentalomas and skeletal muscle mass. The aims of our study were to analyze the skeletal muscle mass in patients with adrenal incidentalomas and to investigate the correlations with hormonal data.Methods: We enrolle...

ea0081rc13.6 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Mild autonomous cortisol secretion in patients with adrenal incidentalomas and raised cardiovascular risk

Sagar Rebecca , Fraser Sheila , Collins Emma , Frood Russell , Scarsbrook Andrew , M Stewart Paul , Abbas Afroze

Background: Adrenal incidentalomas are common and require investigation to exclude malignancy and evidence of hormone overproduction. Clinical guidelines recommend overnight dexamethasone suppression tests (ONDST) to assess for cortisol hypersecretion with cortisol levels of 50-138 nmol/l termed “mild autonomous cortisol secretion” (MACS). MACS may be associated with both cardiovascular and metabolic morbidity. We assessed cardiovascular risk in patients with MACS us...

ea0081rc13.7 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

An observational retrospective study on the association of urine metanephrine levels with cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma

Di Carlo Maria Chiara , Parasiliti Caprino Mirko , Lopez Chiara , Bollati Martina , Bioletto Fabio , Sola Chiara , Ponzetto Federico , Gesmundo Iacopo , Settanni Fabio , Ghigo Ezio , Mengozzi Giulio , Maccario Mauro , GIORDANO Roberta

Background: Several studies argued that the cardiovascular evaluation of patients with nonfunctioning adrenal incidentaloma is of particular importance, even if a direct association seems difficult to underline.Objective: We aimed to evaluate the possibility of stratifying cardiometabolic risk through metanephrine levels in patients with incidentally discovered nonfunctioning adrenal adenoma.Design: In this retrospective cross-sect...

ea0081rc13.8 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Gut dysbiosis in patients with cushing’s syndrome in remission. relationship with cardiometabolic risk

Valassi Elena , Manichanh chaysavanh , Martel Duguech Luciana Maria , Gonzalez Fernandez Pedro , Gaztambide Sonia , Puig-Domingo Manel , Webb Youdale Susan

Background: Patients with Cushing’s syndrome (CS) in remission show residual cardiometabolic derangements leading to increased cardiovascular risk. Impaired characteristics of gut microbiome (dysbiosis), such as richness, diversity and composition, have been associated with several cardiometabolic risk factors, including obesity, insulin resistance and atherosclerosis. Whether CS patients present with intestinal dysbiosis is currently unknown. Our study was aimed at evalu...